CD30+ T cell lymphoproliferative disorders with cutaneous involvement (CD30+ T LPDs) constitute a highly heterogeneous spectrum of diseases that share overlapping histopathologic features. While lymphomatoid papulosis (LyP) represents an indolent, self-resolving entity and nodal anaplastic large cell lymphoma (nALCL) with skin involvement is uniformly aggressive, the remaining entities exhibit divergent clinical outcomes, underscoring the need to define the biological drivers of disease heterogeneity.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: